Nycomed's intranasal fentanyl approved in EU
This article was originally published in Scrip
Executive Summary
The European Commission has approved Nycomed's intranasal formulation of fentanyl citrate, Instanyl, for the treatment of breakthrough pain in adult cancer patients already receiving maintenance opioid therapy for chronic cancer pain.